Perceptive Advisors - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 115 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$355,000
-25.3%
25,0000.0%0.01%
-30.8%
Q1 2018$475,000
+47400.0%
25,000
+9091.2%
0.01%
Q4 2016$1,0000.0%2720.0%0.00%
Q3 2016$1,000
-100.0%
272
-100.0%
0.00%
-100.0%
Q2 2015$8,872,000
-29.3%
800,0000.0%0.53%
-45.2%
Q1 2015$12,544,000
+3.1%
800,0000.0%0.98%
-4.4%
Q4 2014$12,168,000
+41.0%
800,0000.0%1.02%
+10.2%
Q3 2014$8,628,000
-29.4%
800,0000.0%0.93%
-22.7%
Q2 2014$12,216,000
-15.5%
800,0000.0%1.20%
-21.2%
Q1 2014$14,464,000
-28.6%
800,000
-58.5%
1.52%
+82.5%
Q3 2013$20,246,0001,930,0000.83%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Rokos Capital Management LLP 6,474,348$11,394,8520.84%
WASATCH ADVISORS LP 13,642,417$24,010,6540.15%
Avidity Partners Management LP 2,470,000$4,347,2000.14%
Acrisure Capital Management, LLC 75,832$133,4640.14%
Golden State Equity Partners 135,765$238,9460.13%
Long Focus Capital Management, LLC 1,072,000$1,886,7200.11%
KLK CAPITAL MANAGEMENT LLC 44,323$78,0080.10%
CAXTON ASSOCIATES LP 288,218$507,2640.08%
XTX Topco Ltd 206,334$363,1480.08%
Rhenman & Partners Asset Management AB 314,157$534,0670.06%
View complete list of SANGAMO THERAPEUTICS INC shareholders